Zhengjuan Li1,2, Shuoshi Wang1, Liping Li1. 1. Department of Obstetrics, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China. 2. Department of Obstetrics and Gynecology, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
Abstract
Introduction: Advanced oxidation protein products (AOPPs), the novel marker of oxidative stress, have been found to be elevated in preeclampsia (PE). To date, the effect of AOPPs on the senescence of trophoblast cells is still unclear. In this study, we investigated whether AOPPs promoted the senescence of trophoblast cells and explored the underlying mechanisms of AOPPs-induced aging process which may facilitate the progression of PE. Methods: The trophoblast cell line HTR-8/SV neo cells were cultured in the presence of PBS, AOPPs, AOPPs plus an anti-oxidant N-acetyl-L-cysteine (NAC). In some experiments, cells were pre-treated with rapamycin (an activator of autophagy), 3-MA (an inhibitor of autophagy), or cyclic pifithrin-α (PFT-α, an antagonist of p53), and then treated with AOPPs. Cellular senescence was analyzed by measuring the levels of senescence-associated β-galactosidase (SA β-Gal), senescence-associated heterochromatin foci (SAHF), mitochondrial membrane potential (ΔΨm), and cell cycle. Cell autophagic flux was analyzed by measuring tandem fluorescence-tagged LC3 reporter (mCherry-EGFP-LC3). Levels of p53, phosphorylated p53 (p-p53), p21, BECN1, p62, p-mTOR and p-p70S6K were measured by western blot. Results: Treatment with AOPPs significantly increased the levels of SA β-Gal and SAHF, the percentage of cells in the G0/G1 phase, and decreased cell ΔΨm compared with the control group. Co-treatment with NAC and AOPPs significantly reversed AOPPs-induced senescence. Pre-treatment with rapamycin or 3-MA significantly inhibited or promoted AOPPs-induced senescence, respectively. In addition, administration of AOPPs significantly decreased the numbers of mCherry+EGFP+ autophagosomes and mCherry+EGFP- autolysosomes in cells compared with cells treated with PBS. Furthermore, AOPPs significantly increased the levels of proteins p-p53, p21, p-mTOR and p-p70S6K compared with the control group. Pre-treatment with rapamycin or PFT-α significantly down-regulated the levels of SA β-Gal, SAHF, p-p53, p21, autophagy related protein p62, the percentage of cells in the G0/G1 phase, and significantly up-regulated ΔΨm, autophagy related protein BECN1, autophagosomes and autolysosomes compared with cells only treated with AOPPs. Conclusion: AOPPs may induce trophoblast cell senescence by inhibiting the autophagy process in a p53/mTOR/p70S6K-dependent pathway.
Introduction: Advanced oxidation protein products (AOPPs), the novel marker of oxidative stress, have been found to be elevated in preeclampsia (PE). To date, the effect of AOPPs on the senescence of trophoblast cells is still unclear. In this study, we investigated whether AOPPs promoted the senescence of trophoblast cells and explored the underlying mechanisms of AOPPs-induced aging process which may facilitate the progression of PE. Methods: The trophoblast cell line HTR-8/SV neo cells were cultured in the presence of PBS, AOPPs, AOPPs plus an anti-oxidant N-acetyl-L-cysteine (NAC). In some experiments, cells were pre-treated with rapamycin (an activator of autophagy), 3-MA (an inhibitor of autophagy), or cyclic pifithrin-α (PFT-α, an antagonist of p53), and then treated with AOPPs. Cellular senescence was analyzed by measuring the levels of senescence-associated β-galactosidase (SA β-Gal), senescence-associated heterochromatin foci (SAHF), mitochondrial membrane potential (ΔΨm), and cell cycle. Cell autophagic flux was analyzed by measuring tandem fluorescence-tagged LC3 reporter (mCherry-EGFP-LC3). Levels of p53, phosphorylated p53 (p-p53), p21, BECN1, p62, p-mTOR and p-p70S6K were measured by western blot. Results: Treatment with AOPPs significantly increased the levels of SA β-Gal and SAHF, the percentage of cells in the G0/G1 phase, and decreased cell ΔΨm compared with the control group. Co-treatment with NAC and AOPPs significantly reversed AOPPs-induced senescence. Pre-treatment with rapamycin or 3-MA significantly inhibited or promoted AOPPs-induced senescence, respectively. In addition, administration of AOPPs significantly decreased the numbers of mCherry+EGFP+ autophagosomes and mCherry+EGFP- autolysosomes in cells compared with cells treated with PBS. Furthermore, AOPPs significantly increased the levels of proteins p-p53, p21, p-mTOR and p-p70S6K compared with the control group. Pre-treatment with rapamycin or PFT-α significantly down-regulated the levels of SA β-Gal, SAHF, p-p53, p21, autophagy related protein p62, the percentage of cells in the G0/G1 phase, and significantly up-regulated ΔΨm, autophagy related protein BECN1, autophagosomes and autolysosomes compared with cells only treated with AOPPs. Conclusion: AOPPs may induce trophoblast cell senescence by inhibiting the autophagy process in a p53/mTOR/p70S6K-dependent pathway.
Preeclampsia (PE), a complication associated with 2–8% of pregnancies, is an obstetric syndrome induced during pregnancy that not only affects multiple organs and multiple systems in the mother but also impairs the development of the fetus (Steegers et al., 2010). Substantial evidences have suggested that trophoblast cells play a critical role in placental development (Oreshkova et al., 2012; Staud and Karahoda, 2018). Placental trophoblast cells are the structural and biochemical barrier between maternal and fetal tissues. On one hand, trophoblast cells differentiate into extravillous trophoblast cells invading the maternal spiral artery, where trophoblast cells replace the arterial media and transform the uteroplacental circulation into a high-flow, low-resistance system. On the other hand, trophoblast cells interact with decidual stromal cells, immune cells and other non-immune cells that compose the maternal-fetal interface (Oreshkova et al., 2012). Malfunction of trophoblast cells may not only cause a number of complications, including PE and intrauterine growth restriction, but also lead to fetal programming that increases predisposition to various metabolic and central nerve system diseases later in adult life (e.g., type 2 diabetes mellitus, hypertension, metabolic syndrome, depression, schizophrenia and autism spectrum disorders (Staud and Karahoda, 2018)).Advanced oxidation protein products (AOPPs) encompass di-tyrosine containing cross-linked protein products, which mostly form after the oxidation of albumin in-vivo. Evidences have suggested that the expression of AOPPs is higher in diverse diseases, including diabetes (Heidari et al., 2020), obesity (Fejfer et al., 2017) and polycystic ovary syndrome (Melo et al., 2016). Increasing evidences indicate that women with high plasma levels of AOPPs have a higher risk of developing PE during their pregnancies. Karacay et al. (2010) evaluated concentrations of plasma AOPPs in women, including 27 women with gestational diabetes mellitus (GDM), 27 women with PE and 29 women with noncomplicated singleton pregnancies between 24 and 36 weeks of gestation, and found that AOPPs plasma expression significantly elevated in those with PE or GDM. Huang et al. (2013) evaluated concentrations of plasma AOPPs in 22 women with mild PE and 28 women with severe PE. Their data showed that levels of plasma AOPPs arose with the progression of PE, and demonstrated a positive relation between concentrations of plasma AOPPs and 24 h proteinuria excretion. However, Noyan et al. (2006) found that levels of AOPPs in the plasm of women with PE and eclampsia did not have significant differences with normal pregnancy women. Therefore, the role of AOPPs in PE remains to be illuminated.In addition, Komosinska-Vassev et al. (2012) found that concentrations of AOPPs significantly elevated in 177 healthy elderly people compared with young subjects. It has been demonstrated that AOPPs play an important role in vascular endothelia aging (Luna et al., 2016) and aging-associated bone loss (Melough et al., 2017). As a crucial feature of mammalian cells, senescence can be both protective and deathful. Oncogene-triggered senescence can suppress tumor growth (Calcinotto et al., 2019), whereas cell aging may be responsible for atherosclerosis (Wang and Bennett, 2012) and neurodegeneration (Hou et al., 2019). Senescent cells produce a complex secretome, the senescence-associated secretory phenotype (SASP), which can be detrimental in tissue repairing and organ aging (Birch and Gil, 2020). Emerging data have shown that placental oxidative stress is a critical intermediary event in the pathology of PE and intrauterine growth restriction (Hsieh et al., 2012; Zsengellér et al., 2016). Meanwhile, it has been demonstrated that placental senescence might be critical in the pathogenesis of PE (Biron-Shental et al., 2010; Cindrova-Davies et al., 2018). Smith et al. (2013) have hypothesized that oxidative stress causes changes in placental proteins, lipids and DNA, which may induce a form of advanced aging, leads to placental insufficiency and inability to meet the demands of the growing fetus, and ultimately causes fetal demise. Mayne et al. (2017) have analyzed DNA methylation data from publication data and proved that placentas from early-onset PE pregnancies present accelerated aging.Autophagy is a highly orchestrated process involved in the degradation of damaged proteins and organelles inside the cell, and plays an essential role in maintaining genome homeostasis (Dikic and Elazar, 2018). As an evolutionarily conserved catabolic process, autophagy modulates various physiological and pathophysiological situations, including starvation adaptation, clearance of damaged proteins and organelles, development, elimination of pathogens, cell survival and death, tumor suppression, and antigen presentation (Klionsky et al., 2016). Disorder of autophagy causes many diseases, including neurodegenerative diseases (Park et al., 2020) and some metabolic diseases, including insulin resistance, diabetes mellitus, obesity, atherosclerosis and osteoporosis (Kim and Lee, 2014). However, Bernard et al. (Bernard et al., 2020) have shown that in serum starvation, fibroblasts are driven into senescence by sustained autophagy induced by oxidative stress, which can be reversed by inhibiting autophagy. Therefore, our study aimed to investigate the relationship between placental oxidative stress, trophoblast cell senescence, autophagy and the pathogenesis of PE. We found that AOPPs induced trophoblast cell senescence through oxidative stress, and inhibited autophagy process through activating p53 following activating mTOR and its downstream molecule p70S6K.
Materials and Methods
Preparation of AOPPs
AOPPs were prepared as described previously (Witko-Sarsat et al., 1998). Briefly, Bovine serum albumin (BSA, Solarbio, Beijing, China) was exposed to hypochlorous acid (HOCl, Sangon Biotech, Shanghai, China) for 30 min and dialyzed overnight against PBS (Hyclone, South Logan, United States) to remove free HOCl. Concentrations of AOPPs in the preparation were determined using a microplate reader (Model MR 5000, Dynatech, France). The concentrations of BSA were 72.4 ± 9.8 nmol/mg protein in prepared AOPPs-BSA (AOPPs) and 0.2 ± 0.02 nmol/mg protein in PBS-BSA (PBS).
Senescence-Associated β-Galactosidase Stain
To measure cellular senescence, HTR-8/SV neo cells (Shanghai Biological Technology, Shanghai, China), the first-trimester extra-villous trophoblast cell line, were stained with the senescence-associated β-galactosidase (SA β-Gal, a widely accepted senescence marker) (Beyotime Institute of Biotechnology, Nanjing, China) according to the manufacturer’s instruction. In brief, cells were seeded in 6-well plates for 24 h, and then pre-treated with rapamycin (500 nM, Sigma, St. Louis, MO, United States) or 3-MA (2 mM, Sigma) for 1 h, or pre-treated with cyclic pifithrin-α (PFT-α) (30 mM, MCE, New Jersey, United States) for 6 h, and then treated with AOPPs (200 μg/ml) for 48 h. In selected experiments, cells were treated with PBS, AOPPs (200 μg/ml), or AOPPs (200 μg/ml) plus N-acetyl-L-cysteine (NAC) (1 mM, Sigma) for 48 h. Images containing more than 200 cells per high magnification field of view were randomly taken by fluorescent microscope Leica DMI4000B (Leica, Wetzlar, Germany). The numbers of total and blue cells were counted using Image J software (National Institutes of Health, Bethesda, MD, United States). The percentage of SA β-Gal+ cells was calculated as the ratio of the number of blue cells to the number of total cells. The assay was carried out in triplicate and repeated six times independently.
Evaluation of Mitochondrial Membrane Potential (ΔΨm)
HTR-8/SV neo cells were seeded in 12-well plates and cultured for 24 h, and then treated with PBS, AOPPs (200 μg/ml), and AOPPs (200 μg/ml) plus NAC (1 mM). In selected experiments, cells were pre-treated with rapamycin (500 nM) or 3-MA (2 mM) for 1 h, or PFT-α (30 mM) for 6 h, and then treated with AOPPs (200 μg/ml) for 48 h. Evaluation of ΔΨm was conducted using a lipophilic probe 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethyl-benzimidazolylcarbocyanine iodide (JC-1, Sigma), which is able to selectively penetrate mitochondria. In healthy cells with high ΔΨm, JC-1 forms complexes known as J-aggregates, while in unhealthy cells with low ΔΨm, JC-1 remains as the monomeric form. When excited at 510 nm, JC-1 monomers emit a green fluorescence with a maximum at 527 nm. Aggregates of JC-1 emit an orange-red fluorescence with a maximum at 590 nm. A total of 3 × 105 cells were added 0.5 mg/ml JC-1, and incubated for 30 min at 37°C in the dark. Cells were then washed and analyzed by a Beckman flow cytometer (Beckman Coulter, CA, United States). Data was analyzed using FlowJo software (Ashland, OR, United States).
Immunostaining and Confocal Fluorescence Microscopy Assay
HTR-8/SV neo cells were seeded in 96-well plates and cultured for 24 h, and then treated with PBS, AOPPs (200 μg/ml), or AOPPs (200 μg/ml) plus NAC (1 mM) for 48 h. In selected experiments, cells were pre-treated with rapamycin (500 nM) or 3-MA (2 mM) for 1 h, or PFT-α (30 mM) for 6 h, and then treated with AOPPs (200 μg/ml) for 48 h. The formation of senescence-associated heterochromatin foci (SAHF), a senescence marker, can be visualized as the punctate nuclear focus when cells were stained with DAPI (Biolegend, San Diego, CA, United States) and the Ab against K9 tri-methylated histone 3 (K9M-H3, Abcam, Cambridge, MA, United States). For confocal fluorescence analysis, cells were fixed in 4% paraformaldehyde for 20 min at room temperature, and blocked in PBS containing 5% BSA and 0.1% Triton X-100 (all from Sangon Biotech, Shanghai, China). Fixed cells were washed and incubated with rabbit anti-K9M-H3 Ab at 4°C overnight, and then washed and incubated with Alexa Flour 488-conjugated anti-rabbit secondary Ab (Thermo Fisher Scientific, Franklin, MA, United States) at room temperature for 1 h. After washing with PBS, cells were stained with DAPI for 5 min. Samples were observed under the Leica confocal microscopy TCS SP5 (Leica) and analyzed using LCS Leica confocal software (Leica). Cells with condensed imaging of K9M-H3 co-localized with DAPI in the nuclei were considered as SAHF+ cells. Percentages of SAHF+ cells were calculated.
Cell Transfection with mCherry-EGFP-LC3
To directly monitor autophagy flux, a fluorescence assay, tandem monomeric mCherry-EGFP-tagged LC3 was employed. HTR-8/SV neo cells were cultured in 24-well plates for 24 h to reach around 70% confluence. Cells were transfected with a lentivirus-mediated mCherry-EGFP-LC3 (Hanbio company, Shanghai, China) to generate mCherry-EGFP-LC3-expressing cells. According to the manufacturer’s instructions, 250 µl cell culture media containing 2.5 × 105 transducing units of lentivirus was added to the plate. After 4 h of culture, another 250 µl culture media was added, and cells were cultured for 20 h. Subsequently, cells were treated with rapamycin (500 nM) or 3-MA (2 mM) for 1 h, or treated with PFT-α (30 mM) for 6 h, and then treated with AOPPs for 48 h. Cells only treated with AOPPs served as positive controls. Cells only treated with PBS served as negative controls. Cell expression of mCherry (red) or EGFP (green) was observed under the Leica confocal microscopy TCS SP5 (Leica) and analyzed using LCS Leica confocal software (Leica). The assay was carried out in triplicate and repeated six times independently.
Analysis of the Cell Cycle
HTR-8/SV neo cells were seeded in 12-well plates and cultured for 24 h. Cells were then treated with PBS, AOPPs (200 μg/ml), AOPPs (200 μg/ml) plus NAC (1 mM) and cultured for 48 h. In selected experiments, cells were pre-treated with rapamycin (500 nM) or 3-MA (2 mM) for 1 h, or PFT-α (30 mM) for 6 h, and then treated with AOPPs (200 μg/ml) for 48 h. The cell cycle was measured by DNA fragment staining with propidium Iodide (PI, Jiangsu Keygen Biotech, Nanjing, China). According to the manufacturer’s instructions, cells (5 × 105) were washed and fixed with 70% cold ethanol for 2 h at 4 °C. After washing twice with cold PBS, cells were stained with 500 μl working solution containing 450 μl PI solution and 50 μl RNase for 30 min at room temperature. Cells were washed, and the fluorescence intensities of viable cells were measured using a Beckman flow cytometer (Beckman Coulter). Data were analyzed using FlowJo software.
Western Blotting
HTR-8/SV neo cells were seeded in 6-well plates and cultured for 24 h, and then treated with PBS, AOPPs (200 μg/ml), AOPPs (200 μg/ml) plus NAC (1 mM) for 48 h. In selected experiments, cells were pre-treated with rapamycin (500 nM) or 3-MA (2 mM) for 1 h, or PFT-α (30 mM) for 6 h, then treated with AOPPs for 48 h. Cells were subsequently lysed in the lysis buffer (Beyotime Institute of Biotechnology) for 10 min on ice. Cells were centrifugated at 13,000 g for 10 min at 4°C, and the cell lysates were collected. Protein concentrations were determined using the Pierce® BCA protein assay kit (Thermo Fisher Scientific). Approximately 30 μg of protein were separated on the 4–12% Bis–Tris Gel (Genscript, Nanjing, China) and transferred to the PVDF membrane (Millipore, Billerica, MA, United States). The membrane was incubated with primary Abs against p53, p21 (both from Santa Cruz, California, United States), phosphorylated p53 (Ser15) (p-p53), p62, BECN1, p-mTOR (Ser2448), p-p70S6K (Thr389) and β-Actin (all from Cell Signaling Technology, Beverly, MA, United States) overnight at 4°C. The membrane was then washed and incubated with horseradish peroxidase (HRP)-coupled goat-anti-mouse or goat-anti-rabbit secondary Ab IgG (H + L) (Thermo Fisher Scientific). The membrane was washed, and treated with the Pierce® ECL Western Blotting Substrate (Thermo Fisher Scientific) for color exposure. Image J software was used to detect the gray value of the strip. The expression of p-p53 was analyzed semi-quantitatively using p53 as the internal reference protein. The expression of target proteins p53, p21, p62, BECN1, p-mTOR and p-p70S6K was analyzed semi-quantitatively using β-Actin as the internal reference protein.
Statistical Analysis
All statistical analyses were performed using Graphpad Prism eight software (GraphPad, Bethesda, MD, United States). Data were analyzed using one-way ANOVA with Bonferroni test. Results were presented as means ± SDs. A p value of <0.05 was considered significant among analyzed groups.
Results
AOPPs Induced Cell Senescence in an Oxidation-Dependent Manner
As shown in Figure 1A, treatment with AOPPs markedly increased the expression of SA β-Gal on HTR-8/SV neo cells compared with the control group (p <0.01), while co-treatment with AOPPs and NAC, an anti-oxidant, significantly suppressed the effect of AOPPs, demonstrating the role of oxidative stress in AOPPs-induced cell senescence. Mitochondrial membrane potential (ΔΨm) is a critical indicator of mitochondrial function, and decreased ΔΨm is closely associated with cell senescence (Mansell et al., 2021). AOPPs significantly decreased the ΔΨm of HTR-8/SV neo cells, while co-treatment with AOPPs and NAC significantly increased cell ΔΨm compared with cells treated with AOPPs (
p <0.01, Figure 1B). In addition, as shown in Figure 1C, AOPPs significantly increased the percentage of SAHF+ cells as compared to controls (p <0.01), while co-treatment with AOPPs and NAC significantly decreased the percentage of SAHF+ cells compared with cells only treated with AOPPs (p <0.01).
FIGURE 1
AOPPs induce cell senescence in an oxidation-dependent manner. HTR-8/SV neo cells were treated with PBS, AOPPs, or AOPPs plus NAC, and cultured for 48 h. (A) Representative images of SA β-Gal staining (left), and the percentages of SA β-Gal+ cells were presented (right). Scale bar: 50 μm. (B) Representative flow cytometry scatter plots of JC-1 staining were shown, and the cells in the right lower quadrant represented cells with low ΔΨm (left). The histograms represented the percentages of cells with low ΔΨm (right). (C) Immunostaining of K9M-H3 (green) and DAPI (blue) and the representative images of SAHF+ cells (left), and the percentages of SAHF+ cells (right) were presented. Scale bar: 20 μm *
p <0.01.
AOPPs induce cell senescence in an oxidation-dependent manner. HTR-8/SV neo cells were treated with PBS, AOPPs, or AOPPs plus NAC, and cultured for 48 h. (A) Representative images of SA β-Gal staining (left), and the percentages of SA β-Gal+ cells were presented (right). Scale bar: 50 μm. (B) Representative flow cytometry scatter plots of JC-1 staining were shown, and the cells in the right lower quadrant represented cells with low ΔΨm (left). The histograms represented the percentages of cells with low ΔΨm (right). (C) Immunostaining of K9M-H3 (green) and DAPI (blue) and the representative images of SAHF+ cells (left), and the percentages of SAHF+ cells (right) were presented. Scale bar: 20 μm *
p <0.01.
Inhibition of Autophagy Promoted the Pro-Senescent Effect of AOPPs
To investigate whether autophagy was associated with the pro-senescent effect of AOPPs, HTR-8/SV neo cells were pre-treated with rapamycin, an activator of autophagy, or 3-MA, an inhibitor of autophagy, before cells were treated with AOPPs. Our results showed that pre-treatment with rapamycin significantly inhibited AOPPs-increased percentages of SA β-Gal+ cells (Figure 2A). The expression of SA β-Gal was higher in cells treated with 3-MA and AOPPs compared with cells only treated with AOPPs, but the difference was not significant (Figure 2A). In addition, treatment with rapamycin and AOPPs significantly decreased the percentage of low ΔΨm cells compared with cells only treated with AOPPs (p <0.01). While treatment with 3-MA and AOPPs significantly increased the percentage of low ΔΨm cells compared with cells only treated with AOPPs (p <0.05, Figure 2B). Moreover, treatment with rapamycin and AOPPs significantly inhibited AOPPs-increased percentages of SAHF+ cells (Figure 2C), while treatment with 3-MA and AOPPs significantly promoted AOPPs-increased percentages of SAHF+ cells (Figure 2C). Our results suggested that while activating autophagy decreased AOPPs-induced senescence, inhibiting autophagy increased AOPPs-induced senescence.
FIGURE 2
Inhibition of autophagy promoted the pro-senescence effect of AOPPs. Cells were treated with PBS or AOPPs and cultured for 48 h. In selected groups, cells were pre-treated with rapamycin or 3-MA for 1 h, and then treated with AOPPs, and cultured for 48 h. (A) Representative images of SA β-Gal staining (left), and the percentages of SA β-Gal+ cells were presented (right). Scale bar: 50 μm. (B) Representative flow cytometry scatter plots of JC-1 staining were shown, and cells in the right lower quadrant represented cells with low ΔΨm (left). The histograms represented the percentages of cells with low ΔΨm (right). (C) Immunostaining of K9M-H3 (green) and DAPI (blue) and the representative images of SAHF+ cells (left), and the percentages of SAHF+ cells were presented (right). Scale bar: 20 μm. (D) Autophagic flux was measured by analyzing tandem fluorescence-tagged LC3 reporter (mCherry-EGFP-LC3). Yellow mCherry+EGFP+ LC3 puncta represented autophagosomes and red mCherry+EGFP- LC3 puncta represented autolysosomes, and the percentages of autophagosomes and autolysosomes were presented (right). Scale bar: 20 μm. Data were presented as means ± SDs of at least six independent experiments. #
p <0.05, *
p <0.01.
Inhibition of autophagy promoted the pro-senescence effect of AOPPs. Cells were treated with PBS or AOPPs and cultured for 48 h. In selected groups, cells were pre-treated with rapamycin or 3-MA for 1 h, and then treated with AOPPs, and cultured for 48 h. (A) Representative images of SA β-Gal staining (left), and the percentages of SA β-Gal+ cells were presented (right). Scale bar: 50 μm. (B) Representative flow cytometry scatter plots of JC-1 staining were shown, and cells in the right lower quadrant represented cells with low ΔΨm (left). The histograms represented the percentages of cells with low ΔΨm (right). (C) Immunostaining of K9M-H3 (green) and DAPI (blue) and the representative images of SAHF+ cells (left), and the percentages of SAHF+ cells were presented (right). Scale bar: 20 μm. (D) Autophagic flux was measured by analyzing tandem fluorescence-tagged LC3 reporter (mCherry-EGFP-LC3). Yellow mCherry+EGFP+ LC3 puncta represented autophagosomes and red mCherry+EGFP- LC3 puncta represented autolysosomes, and the percentages of autophagosomes and autolysosomes were presented (right). Scale bar: 20 μm. Data were presented as means ± SDs of at least six independent experiments. #
p <0.05, *
p <0.01.We next analyzed autophagic flux by measuring tandem fluorescence-tagged LC3 reporter (mCherry-EGFP-LC3) based on different pH stability of fluorescent proteins EGFP and mCherry. EGFP signal is quenched in the acidic environment when LC3-formed autophagosomes are fused with lysosomes for degradation (Klionsky et al., 2016). Yellow mCherry+EGFP+ LC3 puncta represent autophagosomes and red mCherry+EGFP- LC3 puncta represent autolysosomes (Klionsky et al., 2016). As demonstrated in Figure 2D, there were fewer yellow mCherry+EGFP+ LC3 puncta (autophagosomes) and red mCherry+EGFP- LC3 puncta (autolysosomes) in cells treated with AOPPs compared with the control group (p <0.05 and p <0.01). Treatment with rapamycin and AOPPs significantly increased numbers of yellow autophagosomes and red autolysosomes compared with cells only treated with AOPPs (p <0.05 for both comparisons). Our results indicated that AOPPs inhibited the formation of autophagosomes and autolysosomes in HTR-8/SV neo cells.
Inhibition of p53 Reversed the Pro-Senescence Effect of AOPPs.
p53 Functions as a transcription factor involved in cell-cycle control, DNA repair, apoptosis and cellular stress responses (Rufini et al., 2013; Hafner et al., 2019). In addition, p53 activation also modulates cellular senescence and organismal aging (Rufini et al., 2013; Hafner et al., 2019). To confirm the role of p53 in AOPPs-induced senescence, PFT-α, an antagonist of p53 (Leeper et al., 2013), was employed. Pre-treatment with PFT-α significantly down-regulated AOPPs-increased levels of SA β-Gal (Figure 3A). Treatment with PFT-α and AOPPs significantly decreased the percentages of low ΔΨm cells (p < 0.01, Figure 3B) and SAHF+ cells (p < 0.01, Figure 3C) compared with cells only treated with AOPPs. Meanwhile, pre-treatment with PFT-α significantly increased the yellow autophagosomes and red autolysosomes compared with cells only treated with AOPPs (p <0.01 and p <0.05, Figure 3D). Our data suggested that inhibition of p53 reversed the pro-senescence effect of AOPPs.
FIGURE 3
Inhibition of p53 reversed the pro-senescence effect of AOPPs. HTR-8/SV neo ells were treated with PBS or AOPPs and cultured for 48 h. In selected experiments, cells were pre-treated with PFT-α for 6 h, then treated with AOPPs, and cultured for 48 h. (A) Representative images of SA β-Gal staining (left), and the percentages of SA β-Gal+ cells were presented (right). Scale bar: 50 μm. (B) Representative flow cytometry scatter plots of JC-1 staining were shown, and cells in the right lower quadrant represented cells with low ΔΨm (left). The histograms represented the percentages of cells with low ΔΨm (right). (C) Immunostaining of K9M-H3 (green) and DAPI (blue) and the representative images of SAHF+ cells (left), and the percentages of SAHF+ cells were presented (right). Scale bar: 20 μm. (D) Autophagic flux was measured by analyzing tandem fluorescence-tagged LC3 reporter (mCherry-EGFP-LC3). Yellow mCherry+EGFP+ LC3 puncta represented autophagosomes and red mCherry+EGFP- LC3 puncta represented autolysosomes, and the percentages of autophagosomes and autolysosomes were presented (right). Scale bar: 20 μm. Data were presented as means ± SDs of at least six independent experiments. #
p <0.05, *
p <0.01.
Inhibition of p53 reversed the pro-senescence effect of AOPPs. HTR-8/SV neo ells were treated with PBS or AOPPs and cultured for 48 h. In selected experiments, cells were pre-treated with PFT-α for 6 h, then treated with AOPPs, and cultured for 48 h. (A) Representative images of SA β-Gal staining (left), and the percentages of SA β-Gal+ cells were presented (right). Scale bar: 50 μm. (B) Representative flow cytometry scatter plots of JC-1 staining were shown, and cells in the right lower quadrant represented cells with low ΔΨm (left). The histograms represented the percentages of cells with low ΔΨm (right). (C) Immunostaining of K9M-H3 (green) and DAPI (blue) and the representative images of SAHF+ cells (left), and the percentages of SAHF+ cells were presented (right). Scale bar: 20 μm. (D) Autophagic flux was measured by analyzing tandem fluorescence-tagged LC3 reporter (mCherry-EGFP-LC3). Yellow mCherry+EGFP+ LC3 puncta represented autophagosomes and red mCherry+EGFP- LC3 puncta represented autolysosomes, and the percentages of autophagosomes and autolysosomes were presented (right). Scale bar: 20 μm. Data were presented as means ± SDs of at least six independent experiments. #
p <0.05, *
p <0.01.
AOPPs Induced the Cell Cycle Arrest of Trophoblast Cells
Senescence is an irreversible cell cycle arrest (Calcinotto et al., 2019). We next examined the cell cycle of AOPPs-treated trophoblast cells. As shown in Figure 4, administration of AOPPs significantly increased the percentage of cells in the G0/G1 phase compared with controls (p <0.01). Co-treatment with NAC and AOPPs decreased the percentage of cells in the G0/G1 phase compared with cells only treated with AOPPs (p <0.05). In addition, pre-treatment with rapamycin significantly reduced the percentage of cells in the G0/G1 phase compared with cells only treated with AOPPs (p <0.01). We also found that AOPPs-induced cell cycle arrest was reversed by pre-treatment with PFT-α. In accordance with AOPPs-induced senescence, AOPPs treatment induced trophoblast cell cycle arrest through oxidative stress and inhibiting autophagy, and in a p53-dependent manner.
FIGURE 4
AOPPs treatment induced trophoblast cells cycle arrest. HTR-8/sv neo cells were treated with PBS, AOPPs, or AOPPs plus NAC, and cultured for 48 h. In some experiments, cells were pre-treated with rapamycin or 3-MA for 1 h, or PFT-α for 6 h, and then treated with AOPPs, and cultured for 48 h. Representative flow cytometry scatter plots of PI staining (A) were shown, and the percentages of cells in the G0/G1 cell cycle phase were presented. The histograms represented the percentages of cells in the G0/G1 cell cycle phase (B). Data were presented as means ± SDs of at least six independent experiments. #
p < 0.05, *
p < 0.01.
AOPPs treatment induced trophoblast cells cycle arrest. HTR-8/sv neo cells were treated with PBS, AOPPs, or AOPPs plus NAC, and cultured for 48 h. In some experiments, cells were pre-treated with rapamycin or 3-MA for 1 h, or PFT-α for 6 h, and then treated with AOPPs, and cultured for 48 h. Representative flow cytometry scatter plots of PI staining (A) were shown, and the percentages of cells in the G0/G1 cell cycle phase were presented. The histograms represented the percentages of cells in the G0/G1 cell cycle phase (B). Data were presented as means ± SDs of at least six independent experiments. #
p < 0.05, *
p < 0.01.
AOPPs-Mediated Senescence was Through the p53/mTOR/p70S6K Pathway
Since the p53-p21 pathway plays a critical role in senescence induction (Rufini et al., 2013), we explored the p53-p21 pathway in AOPPs-treated HTR-8/SV neo cells. As shown in Figure 5A, AOPPs significantly increased the protein expression level of both p-p53 (p <0.05) and p21 (p <0.01) compared with the control group. Treatment with NAC attenuated the AOPP-increased expression of p-p53 and p21 (
p <0.01 for both comparisons). Meanwhile, pre-treatment of rapamycin inhibited the up-regulation of the levels of p-p53 (p <0.05) and p21 (p <0.01) induced by AOPPs. In addition, pre-treatment with PFT-α decreased the levels of p-p53 and p21compared with cells only treated with AOPPs (p <0.01 for both comparison).
FIGURE 5
AOPPs-mediated trophoblast cell senescence was though the p53/mTOR/p70S6K pathway. HTR-8/SV neo cells were treated with PBS, AOPPs, or AOPPs plus NAC, and cultured for 48 h. In some selected experiments, cells were pre-treated with rapamycin or 3-MA for 1 h, or PFT-α for 6 h, and then treated with AOPPs, and cultured for 48 h. (A) Immune blots of proteins p53, p-p53 and p21 (left), and the levels of p-p53 and p21 (right) were presented. (B) Immune blots of proteins BECN1 and p62 (left), and the levels of BECN1 and p62 (right) were presented. (C) Immune blots of proteins p-mTOR and p-p70S6K (left), and the levels of p-mTOR and p-p70S6K (right) were presented. Data were presented as means ± SDs of at least six independent experiments. #
p <0.05, *
p <0.01.
AOPPs-mediated trophoblast cell senescence was though the p53/mTOR/p70S6K pathway. HTR-8/SV neo cells were treated with PBS, AOPPs, or AOPPs plus NAC, and cultured for 48 h. In some selected experiments, cells were pre-treated with rapamycin or 3-MA for 1 h, or PFT-α for 6 h, and then treated with AOPPs, and cultured for 48 h. (A) Immune blots of proteins p53, p-p53 and p21 (left), and the levels of p-p53 and p21 (right) were presented. (B) Immune blots of proteins BECN1 and p62 (left), and the levels of BECN1 and p62 (right) were presented. (C) Immune blots of proteins p-mTOR and p-p70S6K (left), and the levels of p-mTOR and p-p70S6K (right) were presented. Data were presented as means ± SDs of at least six independent experiments. #
p <0.05, *
p <0.01.We next examined the expression of proteins BECN1 and p62. BECN1 is a critical component of mammalian autophagy (Yue et al., 2003). The polyubiquitin-binding protein p62 is degraded by autophagy (Pankiv et al., 2007). Therefore, autophagy is accompanied with the up-regulation of BECN1 and down-regulation of p62 (Klionsky et al., 2016). As shown in Figure 5B, treatment with AOPPs significantly decreased the level of BECN1 (p <0.05), but increased the level of p62 (p <0.05) in HTR-8/SV neo cells compared with controls. However, treatment with NAC and AOPPs significantly increased the expression of BECN1 (p <0.01), but decreased the expression of p62 (p <0.01) in HTR-8/SV neo cells compared with cells only treated with AOPPs. In addition, cells pre-treated with rapamycin or PFT-α demonstrated a significantly increased level of BECN1 (p <0.01 for both comparisons) but decreased level of p62 (p <0.01 and p <0.05) compared with cells only treated with AOPPs.We also analyzed the levels of p-mTOR and p-p70S6K, the p53 pathway downstream molecules. As shown in Figure 5C, AOPPs significantly increased the levels of p-mTOR (p <0.01) and p-p70S6K (p <0.05) in HTR-8/SV neo cells compared with controls. In contrast, cells pre-treated with rapamycin significantly decreased the levels of p-mTOR (p <0.01) and p-p70S6K (p <0.05) compared with cells only treated with AOPPs. Moreover, pre-treatment with PFT-α significantly decreased the levels of p-mTOR and p-p70S6K compared with cells only treated with AOPPs (p <0.05 for both comparisons). Our results indicated that AOPPs-induced HTR-8/SV neo cell senescence may through the p53/mTOR/p70S6K pathway.
Discussion
PE is a serious complication that compromises maternal wellbeing and fetal development (Steegers et al., 2010). It has been demonstrated that AOPPs accumulate in the plasm of PE pregnancies (Karacay et al., 2010; Huang et al., 2013). In addition, it has been proved that AOPPs induce trophoblast cell apoptosis by enhancing the oxidative pathway (Wang et al., 2015) and inhibiting the anti-oxidative pathway (Chen et al., 2021). Nevertheless, the relationship between AOPPs and senescence remains unclear.Increased oxidative stress induces the activation of autophagy to clear damaged proteins and organelles and reverses the activation of p-ATM and gamma H2AX induced by the damage of DNA (Guo et al., 2020). If oxidative stress is persistent, DNA damage will be irreversible and then cell senescence and organ malfunction will be induced (Zhou et al., 2021). In our prior study, we have found that treatment with AOPPs significantly increase the level of reactive oxygen species (ROS) in HTR8/SV neo cells (Wang et al., 2015). In the present study, administration of AOPPs induced elevated senescence markers, including SA β-gal, p53-p21 pathway, SAHF, ΔΨm and cell cycle arrest in trophoblast cells. We speculate that AOPPs may play an important role in trophoblast cell senescence.Autophagy, a self-eating cellular process, degrades old or unused macromolecules for energy production or recycling within cells (Mizushima, 2007). It is widely known that BECN1, LC3 and p62 are three commonly used indicators for detecting autophagy (Klionsky et al., 2016). When the autophagy pathway is activated, the levels of BECN1 and LC3 increase, and the level of p62 that binds to LC3 decreases. In our study, treatment with AOPPs down-regulated the expression of autophagy-associated proteins of trophoblast cells. However, pre-treatment with rapamycin, an activator of autophagy, attenuated AOPPs-induced senescence, suggesting that AOPPs may induce trophoblast cell senescence through the inhibition of cell autophagy.Similarly, Nakashima et al. (2020) reported that in early- and late-onset PE pregnancies, a master transcriptional regulator of lysosomal biogenesis the transcription factor EB (TFEB) and its down-stream proteins LAMP1, LAMP2 and cathepsin D decreased compared with normal pregnancies, indicating impaired autophagy in PE pregnancies. Lee et al. (2021) explored the consequences of autophagic deficit in the uterus using tissue-specific atg7 knockout mice, and found aberrations in vascular permeability, increased accumulation of specific vascular factors and defective endothelial junctions in the uterus. Their results have demonstrated that autophagy in the uterine vessel microenvironment is critical for controlling vascular permeability in murine uterus. In addition, it has been repored that AOPPs impair autophagic flux in macrophage by inducing lysosomal dysfunction through the PI3K-Akt-mTOR pathway, and play an important role in Crohn’s disease progression (Liao et al., 2021). Activated autophagy has been reported in the placentae of women with PE (Nakashima et al., 2019). The conflicting results of autophagy in the placentae of preeclamptic women remains unclear and need to be explored.mTOR has been proved to play a key role as the main gateway to autophagy (Rabanal-Ruiz et al., 2017). Zhang et al. (Zhang et al., 2018) have proved that AOPPs inhibit autophagy in renal tubular epithelial cells via activation of the PI3K/AKT/mTOR pathway. In addition, Feng et al. (Feng et al., 2005) have reported that p53 and mTOR signaling machineries can cross-talk and coordinately regulate cell growth, proliferation and death. To further investigate the underlying relationship between p53 and mTOR in AOPPs-induced pro-aging effect, we examined the levels of p-mTOR, and its down-stream molecule p-p70S6K protein in HTR-8/SV neo cells treated with AOPPs and PFT-α. We found that AOPPs treatment activated mTOR and its downstream molecular p70S6K, which can be reversed by PFT-α. Our results demonstrated that AOPPs inhibits autophagy in a p53/mTOR/p70S6K-dependent manner. Likewise, it has been reported that autophagy-deficient human extravillous trophoblast cells exhibit poor nuclear translocation of TFEB, reduced expression and defected function of lysosomal proteins, and increased activity of mechanistic target of rapamycin complex 1 (MTORC1) (Nakashima et al., 2020).In summary, AOPPs may induce trophoblast cell senescence through inhibiting autophagy in a p53/mTOR/p70S6K-dependent manner. Our findings revealed a novel mechanism underlying AOPPs-induced trophoblast cell senescence, which may play a role in the pathogenesis of PE.
Authors: V Witko-Sarsat; M Friedlander; T Nguyen Khoa; C Capeillère-Blandin; A T Nguyen; S Canteloup; J M Dayer; P Jungers; T Drüeke; B Descamps-Latscha Journal: J Immunol Date: 1998-09-01 Impact factor: 5.422
Authors: Daniel J Klionsky; Kotb Abdelmohsen; Akihisa Abe; Md Joynal Abedin; Hagai Abeliovich; Abraham Acevedo Arozena; Hiroaki Adachi; Christopher M Adams; Peter D Adams; Khosrow Adeli; Peter J Adhihetty; Sharon G Adler; Galila Agam; Rajesh Agarwal; Manish K Aghi; Maria Agnello; Patrizia Agostinis; Patricia V Aguilar; Julio Aguirre-Ghiso; Edoardo M Airoldi; Slimane Ait-Si-Ali; Takahiko Akematsu; Emmanuel T Akporiaye; Mohamed Al-Rubeai; Guillermo M Albaiceta; Chris Albanese; Diego Albani; Matthew L Albert; Jesus Aldudo; Hana Algül; Mehrdad Alirezaei; Iraide Alloza; Alexandru Almasan; Maylin Almonte-Beceril; Emad S Alnemri; Covadonga Alonso; Nihal Altan-Bonnet; Dario C Altieri; Silvia Alvarez; Lydia Alvarez-Erviti; Sandro Alves; Giuseppina Amadoro; Atsuo Amano; Consuelo Amantini; Santiago Ambrosio; Ivano Amelio; Amal O Amer; Mohamed Amessou; Angelika Amon; Zhenyi An; Frank A Anania; Stig U Andersen; Usha P Andley; Catherine K Andreadi; Nathalie Andrieu-Abadie; Alberto Anel; David K Ann; Shailendra Anoopkumar-Dukie; Manuela Antonioli; Hiroshi Aoki; Nadezda Apostolova; Saveria Aquila; Katia Aquilano; Koichi Araki; Eli Arama; Agustin Aranda; Jun Araya; Alexandre Arcaro; Esperanza Arias; Hirokazu Arimoto; Aileen R Ariosa; Jane L Armstrong; Thierry Arnould; Ivica Arsov; Katsuhiko Asanuma; Valerie Askanas; Eric Asselin; Ryuichiro Atarashi; Sally S Atherton; Julie D Atkin; Laura D Attardi; Patrick Auberger; Georg Auburger; Laure Aurelian; Riccardo Autelli; Laura Avagliano; Maria Laura Avantaggiati; Limor Avrahami; Suresh Awale; Neelam Azad; Tiziana Bachetti; Jonathan M Backer; Dong-Hun Bae; Jae-Sung Bae; Ok-Nam Bae; Soo Han Bae; Eric H Baehrecke; Seung-Hoon Baek; Stephen Baghdiguian; Agnieszka Bagniewska-Zadworna; Hua Bai; Jie Bai; Xue-Yuan Bai; Yannick Bailly; Kithiganahalli Narayanaswamy Balaji; Walter Balduini; Andrea Ballabio; Rena Balzan; Rajkumar Banerjee; Gábor Bánhegyi; Haijun Bao; Benoit Barbeau; Maria D Barrachina; Esther Barreiro; Bonnie Bartel; Alberto Bartolomé; Diane C Bassham; Maria Teresa Bassi; Robert C Bast; Alakananda Basu; Maria Teresa Batista; Henri Batoko; Maurizio Battino; Kyle Bauckman; Bradley L Baumgarner; K Ulrich Bayer; Rupert Beale; Jean-François Beaulieu; George R Beck; Christoph Becker; J David Beckham; Pierre-André Bédard; Patrick J Bednarski; Thomas J Begley; Christian Behl; Christian Behrends; Georg Mn Behrens; Kevin E Behrns; Eloy Bejarano; Amine Belaid; Francesca Belleudi; Giovanni Bénard; Guy Berchem; Daniele Bergamaschi; Matteo Bergami; Ben Berkhout; Laura Berliocchi; Amélie Bernard; Monique Bernard; Francesca Bernassola; Anne Bertolotti; Amanda S Bess; Sébastien Besteiro; Saverio Bettuzzi; Savita Bhalla; Shalmoli Bhattacharyya; Sujit K Bhutia; Caroline Biagosch; Michele Wolfe Bianchi; Martine Biard-Piechaczyk; Viktor Billes; Claudia Bincoletto; Baris Bingol; Sara W Bird; Marc Bitoun; Ivana Bjedov; Craig Blackstone; Lionel Blanc; Guillermo A Blanco; Heidi Kiil Blomhoff; Emilio Boada-Romero; Stefan Böckler; Marianne Boes; Kathleen Boesze-Battaglia; Lawrence H Boise; Alessandra Bolino; Andrea Boman; Paolo Bonaldo; Matteo Bordi; Jürgen Bosch; Luis M Botana; Joelle Botti; German Bou; Marina Bouché; Marion Bouchecareilh; Marie-Josée Boucher; Michael E Boulton; Sebastien G Bouret; Patricia Boya; Michaël Boyer-Guittaut; Peter V Bozhkov; Nathan Brady; Vania Mm Braga; Claudio Brancolini; Gerhard H Braus; José M Bravo-San Pedro; Lisa A Brennan; Emery H Bresnick; Patrick Brest; Dave Bridges; Marie-Agnès Bringer; Marisa Brini; Glauber C Brito; Bertha Brodin; Paul S Brookes; Eric J Brown; Karen Brown; Hal E Broxmeyer; Alain Bruhat; Patricia Chakur Brum; John H Brumell; Nicola Brunetti-Pierri; Robert J Bryson-Richardson; Shilpa Buch; Alastair M Buchan; Hikmet Budak; Dmitry V Bulavin; Scott J Bultman; Geert Bultynck; Vladimir Bumbasirevic; Yan Burelle; Robert E Burke; Margit Burmeister; Peter Bütikofer; Laura Caberlotto; Ken Cadwell; Monika Cahova; Dongsheng Cai; Jingjing Cai; Qian Cai; Sara Calatayud; Nadine Camougrand; Michelangelo Campanella; Grant R Campbell; Matthew Campbell; Silvia Campello; Robin Candau; Isabella Caniggia; Lavinia Cantoni; Lizhi Cao; Allan B Caplan; Michele Caraglia; Claudio Cardinali; Sandra Morais Cardoso; Jennifer S Carew; Laura A Carleton; Cathleen R Carlin; Silvia Carloni; Sven R Carlsson; Didac Carmona-Gutierrez; Leticia Am Carneiro; Oliana Carnevali; Serena Carra; Alice Carrier; Bernadette Carroll; Caty Casas; Josefina Casas; Giuliana Cassinelli; Perrine Castets; Susana Castro-Obregon; Gabriella Cavallini; Isabella Ceccherini; Francesco Cecconi; Arthur I Cederbaum; Valentín Ceña; Simone Cenci; Claudia Cerella; Davide Cervia; Silvia Cetrullo; Hassan Chaachouay; Han-Jung Chae; Andrei S Chagin; Chee-Yin Chai; Gopal Chakrabarti; Georgios Chamilos; Edmond Yw Chan; Matthew Tv Chan; Dhyan Chandra; Pallavi Chandra; Chih-Peng Chang; Raymond Chuen-Chung Chang; Ta Yuan Chang; John C Chatham; Saurabh Chatterjee; Santosh Chauhan; Yongsheng Che; Michael E Cheetham; Rajkumar Cheluvappa; Chun-Jung Chen; Gang Chen; Guang-Chao Chen; Guoqiang Chen; Hongzhuan Chen; Jeff W Chen; Jian-Kang Chen; Min Chen; Mingzhou Chen; Peiwen Chen; Qi Chen; Quan Chen; Shang-Der Chen; Si Chen; Steve S-L Chen; Wei Chen; Wei-Jung Chen; Wen Qiang Chen; Wenli Chen; Xiangmei Chen; Yau-Hung Chen; Ye-Guang Chen; Yin Chen; Yingyu Chen; Yongshun Chen; Yu-Jen Chen; Yue-Qin Chen; Yujie Chen; Zhen Chen; Zhong Chen; Alan Cheng; Christopher Hk Cheng; Hua Cheng; Heesun Cheong; Sara Cherry; Jason Chesney; Chun Hei Antonio Cheung; Eric Chevet; Hsiang Cheng Chi; Sung-Gil Chi; Fulvio Chiacchiera; Hui-Ling Chiang; Roberto Chiarelli; Mario Chiariello; Marcello Chieppa; Lih-Shen Chin; Mario Chiong; Gigi Nc Chiu; Dong-Hyung Cho; Ssang-Goo Cho; William C Cho; Yong-Yeon Cho; Young-Seok Cho; Augustine Mk Choi; Eui-Ju Choi; Eun-Kyoung Choi; Jayoung Choi; Mary E Choi; Seung-Il Choi; Tsui-Fen Chou; Salem Chouaib; Divaker Choubey; Vinay Choubey; Kuan-Chih Chow; Kamal Chowdhury; Charleen T Chu; Tsung-Hsien Chuang; Taehoon Chun; Hyewon Chung; Taijoon Chung; Yuen-Li Chung; Yong-Joon Chwae; Valentina Cianfanelli; Roberto Ciarcia; Iwona A Ciechomska; Maria Rosa Ciriolo; Mara Cirone; Sofie Claerhout; Michael J Clague; Joan Clària; Peter Gh Clarke; Robert Clarke; Emilio Clementi; Cédric Cleyrat; Miriam Cnop; Eliana M Coccia; Tiziana Cocco; Patrice Codogno; Jörn Coers; Ezra Ew Cohen; David Colecchia; Luisa Coletto; Núria S Coll; Emma Colucci-Guyon; Sergio Comincini; Maria Condello; Katherine L Cook; Graham H Coombs; Cynthia D Cooper; J Mark Cooper; Isabelle Coppens; Maria Tiziana Corasaniti; Marco Corazzari; Ramon Corbalan; Elisabeth Corcelle-Termeau; Mario D Cordero; Cristina Corral-Ramos; Olga Corti; Andrea Cossarizza; Paola Costelli; Safia Costes; Susan L Cotman; Ana Coto-Montes; Sandra Cottet; Eduardo Couve; Lori R Covey; L Ashley Cowart; Jeffery S Cox; Fraser P Coxon; Carolyn B Coyne; Mark S Cragg; Rolf J Craven; Tiziana Crepaldi; Jose L Crespo; Alfredo Criollo; Valeria Crippa; Maria Teresa Cruz; Ana Maria Cuervo; Jose M Cuezva; Taixing Cui; Pedro R Cutillas; Mark J Czaja; Maria F Czyzyk-Krzeska; Ruben K Dagda; Uta Dahmen; Chunsun Dai; Wenjie Dai; Yun Dai; Kevin N Dalby; Luisa Dalla Valle; Guillaume Dalmasso; Marcello D'Amelio; Markus Damme; Arlette Darfeuille-Michaud; Catherine Dargemont; Victor M Darley-Usmar; Srinivasan Dasarathy; Biplab Dasgupta; Srikanta Dash; Crispin R Dass; Hazel Marie Davey; Lester M Davids; David Dávila; Roger J Davis; Ted M Dawson; Valina L Dawson; Paula Daza; Jackie de Belleroche; Paul de Figueiredo; Regina Celia Bressan Queiroz de Figueiredo; José de la Fuente; Luisa De Martino; Antonella De Matteis; Guido Ry De Meyer; Angelo De Milito; Mauro De Santi; Wanderley de Souza; Vincenzo De Tata; Daniela De Zio; Jayanta Debnath; Reinhard Dechant; Jean-Paul Decuypere; Shane Deegan; Benjamin Dehay; Barbara Del Bello; Dominic P Del Re; Régis Delage-Mourroux; Lea Md Delbridge; Louise Deldicque; Elizabeth Delorme-Axford; Yizhen Deng; Joern Dengjel; Melanie Denizot; Paul Dent; Channing J Der; Vojo Deretic; Benoît Derrien; Eric Deutsch; Timothy P Devarenne; Rodney J Devenish; Sabrina Di Bartolomeo; Nicola Di Daniele; Fabio Di Domenico; Alessia Di Nardo; Simone Di Paola; Antonio Di Pietro; Livia Di Renzo; Aaron DiAntonio; Guillermo Díaz-Araya; Ines Díaz-Laviada; Maria T Diaz-Meco; Javier Diaz-Nido; Chad A Dickey; Robert C Dickson; Marc Diederich; Paul Digard; Ivan Dikic; Savithrama P Dinesh-Kumar; Chan Ding; Wen-Xing Ding; Zufeng Ding; Luciana Dini; Jörg Hw Distler; Abhinav Diwan; Mojgan Djavaheri-Mergny; Kostyantyn Dmytruk; Renwick Cj Dobson; Volker Doetsch; Karol Dokladny; Svetlana Dokudovskaya; Massimo Donadelli; X Charlie Dong; Xiaonan Dong; Zheng Dong; Terrence M Donohue; Kelly S Doran; Gabriella D'Orazi; Gerald W Dorn; Victor Dosenko; Sami Dridi; Liat Drucker; Jie Du; Li-Lin Du; Lihuan Du; André du Toit; Priyamvada Dua; Lei Duan; Pu Duann; Vikash Kumar Dubey; Michael R Duchen; Michel A Duchosal; Helene Duez; Isabelle Dugail; Verónica I Dumit; Mara C Duncan; Elaine A Dunlop; William A Dunn; Nicolas Dupont; Luc Dupuis; Raúl V Durán; Thomas M Durcan; Stéphane Duvezin-Caubet; Umamaheswar Duvvuri; Vinay Eapen; Darius Ebrahimi-Fakhari; Arnaud Echard; Leopold Eckhart; Charles L Edelstein; Aimee L Edinger; Ludwig Eichinger; Tobias Eisenberg; Avital Eisenberg-Lerner; N Tony Eissa; Wafik S El-Deiry; Victoria El-Khoury; Zvulun Elazar; Hagit Eldar-Finkelman; Chris Jh Elliott; Enzo Emanuele; Urban Emmenegger; Nikolai Engedal; Anna-Mart Engelbrecht; Simone Engelender; Jorrit M Enserink; Ralf Erdmann; Jekaterina Erenpreisa; Rajaraman Eri; Jason L Eriksen; Andreja Erman; Ricardo Escalante; Eeva-Liisa Eskelinen; Lucile Espert; Lorena Esteban-Martínez; Thomas J Evans; Mario Fabri; Gemma Fabrias; Cinzia Fabrizi; Antonio Facchiano; Nils J Færgeman; Alberto Faggioni; W Douglas Fairlie; Chunhai Fan; Daping Fan; Jie Fan; Shengyun Fang; Manolis Fanto; Alessandro Fanzani; Thomas Farkas; Mathias Faure; Francois B Favier; Howard Fearnhead; Massimo Federici; Erkang Fei; Tania C Felizardo; Hua Feng; Yibin Feng; Yuchen Feng; Thomas A Ferguson; Álvaro F Fernández; Maite G Fernandez-Barrena; Jose C Fernandez-Checa; Arsenio Fernández-López; Martin E Fernandez-Zapico; Olivier Feron; Elisabetta Ferraro; Carmen Veríssima Ferreira-Halder; Laszlo Fesus; Ralph Feuer; Fabienne C Fiesel; Eduardo C Filippi-Chiela; Giuseppe Filomeni; Gian Maria Fimia; John H Fingert; Steven Finkbeiner; Toren Finkel; Filomena Fiorito; Paul B Fisher; Marc Flajolet; Flavio Flamigni; Oliver Florey; Salvatore Florio; R Andres Floto; Marco Folini; Carlo Follo; Edward A Fon; Francesco Fornai; Franco Fortunato; Alessandro Fraldi; Rodrigo Franco; Arnaud Francois; Aurélie François; Lisa B Frankel; Iain Dc Fraser; Norbert Frey; Damien G Freyssenet; Christian Frezza; Scott L Friedman; Daniel E Frigo; Dongxu Fu; José M Fuentes; Juan Fueyo; Yoshio Fujitani; Yuuki Fujiwara; Mikihiro Fujiya; Mitsunori Fukuda; Simone Fulda; Carmela Fusco; Bozena Gabryel; Matthias Gaestel; Philippe Gailly; Malgorzata Gajewska; Sehamuddin Galadari; Gad Galili; Inmaculada Galindo; Maria F Galindo; Giovanna Galliciotti; Lorenzo Galluzzi; Luca Galluzzi; Vincent Galy; Noor Gammoh; Sam Gandy; Anand K Ganesan; Swamynathan Ganesan; Ian G Ganley; Monique Gannagé; Fen-Biao Gao; Feng Gao; Jian-Xin Gao; Lorena García Nannig; Eleonora García Véscovi; Marina Garcia-Macía; Carmen Garcia-Ruiz; Abhishek D Garg; Pramod Kumar Garg; Ricardo Gargini; Nils Christian Gassen; Damián Gatica; Evelina Gatti; Julie Gavard; Evripidis Gavathiotis; Liang Ge; Pengfei Ge; Shengfang Ge; Po-Wu Gean; Vania Gelmetti; Armando A Genazzani; Jiefei Geng; Pascal Genschik; Lisa Gerner; Jason E Gestwicki; David A Gewirtz; Saeid Ghavami; Eric Ghigo; Debabrata Ghosh; Anna Maria Giammarioli; Francesca Giampieri; Claudia Giampietri; Alexandra Giatromanolaki; Derrick J Gibbings; Lara Gibellini; Spencer B Gibson; Vanessa Ginet; Antonio Giordano; Flaviano Giorgini; Elisa Giovannetti; Stephen E Girardin; Suzana Gispert; Sandy Giuliano; Candece L Gladson; Alvaro Glavic; Martin Gleave; Nelly Godefroy; Robert M Gogal; Kuppan Gokulan; Gustavo H Goldman; Delia Goletti; Michael S Goligorsky; Aldrin V Gomes; Ligia C Gomes; Hernando Gomez; Candelaria Gomez-Manzano; Rubén Gómez-Sánchez; Dawit Ap Gonçalves; Ebru Goncu; Qingqiu Gong; Céline Gongora; Carlos B Gonzalez; Pedro Gonzalez-Alegre; Pilar Gonzalez-Cabo; Rosa Ana González-Polo; Ing Swie Goping; Carlos Gorbea; Nikolai V Gorbunov; Daphne R Goring; Adrienne M Gorman; Sharon M Gorski; Sandro Goruppi; Shino Goto-Yamada; Cecilia Gotor; Roberta A Gottlieb; Illana Gozes; Devrim Gozuacik; Yacine Graba; Martin Graef; Giovanna E Granato; Gary Dean Grant; Steven Grant; Giovanni Luca Gravina; Douglas R Green; Alexander Greenhough; Michael T Greenwood; Benedetto Grimaldi; Frédéric Gros; Charles Grose; Jean-Francois Groulx; Florian Gruber; Paolo Grumati; Tilman Grune; Jun-Lin Guan; Kun-Liang Guan; Barbara Guerra; Carlos Guillen; Kailash Gulshan; Jan Gunst; Chuanyong Guo; Lei Guo; Ming Guo; Wenjie Guo; Xu-Guang Guo; Andrea A Gust; Åsa B Gustafsson; Elaine Gutierrez; Maximiliano G Gutierrez; Ho-Shin Gwak; Albert Haas; James E Haber; Shinji Hadano; Monica Hagedorn; David R Hahn; Andrew J Halayko; Anne Hamacher-Brady; Kozo Hamada; Ahmed Hamai; Andrea Hamann; Maho Hamasaki; Isabelle Hamer; Qutayba Hamid; Ester M Hammond; Feng Han; Weidong Han; James T Handa; John A Hanover; Malene Hansen; Masaru Harada; Ljubica Harhaji-Trajkovic; J Wade Harper; Abdel Halim Harrath; Adrian L Harris; James Harris; Udo Hasler; Peter Hasselblatt; Kazuhisa Hasui; Robert G Hawley; Teresa S Hawley; Congcong He; Cynthia Y He; Fengtian He; Gu He; Rong-Rong He; Xian-Hui He; You-Wen He; Yu-Ying He; Joan K Heath; Marie-Josée Hébert; Robert A Heinzen; Gudmundur Vignir Helgason; Michael Hensel; Elizabeth P Henske; Chengtao Her; Paul K Herman; Agustín Hernández; Carlos Hernandez; Sonia Hernández-Tiedra; Claudio Hetz; P Robin Hiesinger; Katsumi Higaki; Sabine Hilfiker; Bradford G Hill; Joseph A Hill; William D Hill; Keisuke Hino; Daniel Hofius; Paul Hofman; Günter U Höglinger; Jörg Höhfeld; Marina K Holz; Yonggeun Hong; David A Hood; Jeroen Jm Hoozemans; Thorsten Hoppe; Chin Hsu; Chin-Yuan Hsu; Li-Chung Hsu; Dong Hu; Guochang Hu; Hong-Ming Hu; Hongbo Hu; Ming Chang Hu; Yu-Chen Hu; Zhuo-Wei Hu; Fang Hua; Ya Hua; Canhua Huang; Huey-Lan Huang; Kuo-How Huang; Kuo-Yang Huang; Shile Huang; Shiqian Huang; Wei-Pang Huang; Yi-Ran Huang; Yong Huang; Yunfei Huang; Tobias B Huber; Patricia Huebbe; Won-Ki Huh; Juha J Hulmi; Gang Min Hur; James H Hurley; Zvenyslava Husak; Sabah Na Hussain; Salik Hussain; Jung Jin Hwang; Seungmin Hwang; Thomas Is Hwang; Atsuhiro Ichihara; Yuzuru Imai; Carol Imbriano; Megumi Inomata; Takeshi Into; Valentina Iovane; Juan L Iovanna; Renato V Iozzo; Nancy Y Ip; Javier E Irazoqui; Pablo Iribarren; Yoshitaka Isaka; Aleksandra J Isakovic; Harry Ischiropoulos; Jeffrey S Isenberg; Mohammad Ishaq; Hiroyuki Ishida; Isao Ishii; Jane E Ishmael; Ciro Isidoro; Ken-Ichi Isobe; Erika Isono; Shohreh Issazadeh-Navikas; Koji Itahana; Eisuke Itakura; Andrei I Ivanov; Anand Krishnan V Iyer; José M Izquierdo; Yotaro Izumi; Valentina Izzo; Marja Jäättelä; Nadia Jaber; Daniel John Jackson; William T Jackson; Tony George Jacob; Thomas S Jacques; Chinnaswamy Jagannath; Ashish Jain; Nihar Ranjan Jana; Byoung Kuk Jang; Alkesh Jani; Bassam Janji; Paulo Roberto Jannig; Patric J Jansson; Steve Jean; Marina Jendrach; Ju-Hong Jeon; Niels Jessen; Eui-Bae Jeung; Kailiang Jia; Lijun Jia; Hong Jiang; Hongchi Jiang; Liwen Jiang; Teng Jiang; Xiaoyan Jiang; Xuejun Jiang; Xuejun Jiang; Ying Jiang; Yongjun Jiang; Alberto Jiménez; Cheng Jin; Hongchuan Jin; Lei Jin; Meiyan Jin; Shengkan Jin; Umesh Kumar Jinwal; Eun-Kyeong Jo; Terje Johansen; Daniel E Johnson; Gail Vw Johnson; James D Johnson; Eric Jonasch; Chris Jones; Leo Ab Joosten; Joaquin Jordan; Anna-Maria Joseph; Bertrand Joseph; Annie M Joubert; Dianwen Ju; Jingfang Ju; Hsueh-Fen Juan; Katrin Juenemann; Gábor Juhász; Hye Seung Jung; Jae U Jung; Yong-Keun Jung; Heinz Jungbluth; Matthew J Justice; Barry Jutten; Nadeem O Kaakoush; Kai Kaarniranta; Allen Kaasik; Tomohiro Kabuta; Bertrand Kaeffer; Katarina Kågedal; Alon Kahana; Shingo Kajimura; Or Kakhlon; Manjula Kalia; Dhan V Kalvakolanu; Yoshiaki Kamada; Konstantinos Kambas; Vitaliy O Kaminskyy; Harm H Kampinga; Mustapha Kandouz; Chanhee Kang; Rui Kang; Tae-Cheon Kang; Tomotake Kanki; Thirumala-Devi Kanneganti; Haruo Kanno; Anumantha G Kanthasamy; Marc Kantorow; Maria Kaparakis-Liaskos; Orsolya Kapuy; Vassiliki Karantza; Md Razaul Karim; Parimal Karmakar; Arthur Kaser; Susmita Kaushik; Thomas Kawula; A Murat Kaynar; Po-Yuan Ke; Zun-Ji Ke; John H Kehrl; Kate E Keller; Jongsook Kim Kemper; Anne K Kenworthy; Oliver Kepp; Andreas Kern; Santosh Kesari; David Kessel; Robin Ketteler; Isis do Carmo Kettelhut; Bilon Khambu; Muzamil Majid Khan; Vinoth Km Khandelwal; Sangeeta Khare; Juliann G Kiang; Amy A Kiger; Akio Kihara; Arianna L Kim; Cheol Hyeon Kim; Deok Ryong Kim; Do-Hyung Kim; Eung Kweon Kim; Hye Young Kim; Hyung-Ryong Kim; Jae-Sung Kim; Jeong Hun Kim; Jin Cheon Kim; Jin Hyoung Kim; Kwang Woon Kim; Michael D Kim; Moon-Moo Kim; Peter K Kim; Seong Who Kim; Soo-Youl Kim; Yong-Sun Kim; Yonghyun Kim; Adi Kimchi; Alec C Kimmelman; Tomonori Kimura; Jason S King; Karla Kirkegaard; Vladimir Kirkin; Lorrie A Kirshenbaum; Shuji Kishi; Yasuo Kitajima; Katsuhiko Kitamoto; Yasushi Kitaoka; Kaio Kitazato; Rudolf A Kley; Walter T Klimecki; Michael Klinkenberg; Jochen Klucken; Helene Knævelsrud; Erwin Knecht; Laura Knuppertz; Jiunn-Liang Ko; Satoru Kobayashi; Jan C Koch; Christelle Koechlin-Ramonatxo; Ulrich Koenig; Young Ho Koh; Katja Köhler; Sepp D Kohlwein; Masato Koike; Masaaki Komatsu; Eiki Kominami; Dexin Kong; Hee Jeong Kong; Eumorphia G Konstantakou; Benjamin T Kopp; Tamas Korcsmaros; Laura Korhonen; Viktor I Korolchuk; Nadya V Koshkina; Yanjun Kou; Michael I Koukourakis; Constantinos Koumenis; Attila L Kovács; Tibor Kovács; Werner J Kovacs; Daisuke Koya; Claudine Kraft; Dimitri Krainc; Helmut Kramer; Tamara Kravic-Stevovic; Wilhelm Krek; Carole Kretz-Remy; Roswitha Krick; Malathi Krishnamurthy; Janos Kriston-Vizi; Guido Kroemer; Michael C Kruer; Rejko Kruger; Nicholas T Ktistakis; Kazuyuki Kuchitsu; Christian Kuhn; Addanki Pratap Kumar; Anuj Kumar; Ashok Kumar; Deepak Kumar; Dhiraj Kumar; Rakesh Kumar; Sharad Kumar; Mondira Kundu; Hsing-Jien Kung; Atsushi Kuno; Sheng-Han Kuo; Jeff Kuret; Tino Kurz; Terry Kwok; Taeg Kyu Kwon; Yong Tae Kwon; Irene Kyrmizi; Albert R La Spada; Frank Lafont; Tim Lahm; Aparna Lakkaraju; Truong Lam; Trond Lamark; Steve Lancel; Terry H Landowski; Darius J R Lane; Jon D Lane; Cinzia Lanzi; Pierre Lapaquette; Louis R Lapierre; Jocelyn Laporte; Johanna Laukkarinen; Gordon W Laurie; Sergio Lavandero; Lena Lavie; Matthew J LaVoie; Betty Yuen Kwan Law; Helen Ka-Wai Law; Kelsey B Law; Robert Layfield; Pedro A Lazo; Laurent Le Cam; Karine G Le Roch; Hervé Le Stunff; Vijittra Leardkamolkarn; Marc Lecuit; Byung-Hoon Lee; Che-Hsin Lee; Erinna F Lee; Gyun Min Lee; He-Jin Lee; Hsinyu Lee; Jae Keun Lee; Jongdae Lee; Ju-Hyun Lee; Jun Hee Lee; Michael Lee; Myung-Shik Lee; Patty J Lee; Sam W Lee; Seung-Jae Lee; Shiow-Ju Lee; Stella Y Lee; Sug Hyung Lee; Sung Sik Lee; Sung-Joon Lee; Sunhee Lee; Ying-Ray Lee; Yong J Lee; Young H Lee; Christiaan Leeuwenburgh; Sylvain Lefort; Renaud Legouis; Jinzhi Lei; Qun-Ying Lei; David A Leib; Gil Leibowitz; Istvan Lekli; Stéphane D Lemaire; John J Lemasters; Marius K Lemberg; Antoinette Lemoine; Shuilong Leng; Guido Lenz; Paola Lenzi; Lilach O Lerman; Daniele Lettieri Barbato; Julia I-Ju Leu; Hing Y Leung; Beth Levine; Patrick A Lewis; Frank Lezoualc'h; Chi Li; Faqiang Li; Feng-Jun Li; Jun Li; Ke Li; Lian Li; Min Li; Min Li; Qiang Li; Rui Li; Sheng Li; Wei Li; Wei Li; Xiaotao Li; Yumin Li; Jiqin Lian; Chengyu Liang; Qiangrong Liang; Yulin Liao; Joana Liberal; Pawel P Liberski; Pearl Lie; Andrew P Lieberman; Hyunjung Jade Lim; Kah-Leong Lim; Kyu Lim; Raquel T Lima; Chang-Shen Lin; Chiou-Feng Lin; Fang Lin; Fangming Lin; Fu-Cheng Lin; Kui Lin; Kwang-Huei Lin; Pei-Hui Lin; Tianwei Lin; Wan-Wan Lin; Yee-Shin Lin; Yong Lin; Rafael Linden; Dan Lindholm; Lisa M Lindqvist; Paul Lingor; Andreas Linkermann; Lance A Liotta; Marta M Lipinski; Vitor A Lira; Michael P Lisanti; Paloma B Liton; Bo Liu; Chong Liu; Chun-Feng Liu; Fei Liu; Hung-Jen Liu; Jianxun Liu; Jing-Jing Liu; Jing-Lan Liu; Ke Liu; Leyuan Liu; Liang Liu; Quentin Liu; Rong-Yu Liu; Shiming Liu; Shuwen Liu; Wei Liu; Xian-De Liu; Xiangguo Liu; Xiao-Hong Liu; Xinfeng Liu; Xu Liu; Xueqin Liu; Yang Liu; Yule Liu; Zexian Liu; Zhe Liu; Juan P Liuzzi; Gérard Lizard; Mila Ljujic; Irfan J Lodhi; Susan E Logue; Bal L Lokeshwar; Yun Chau Long; Sagar Lonial; Benjamin Loos; Carlos López-Otín; Cristina López-Vicario; Mar Lorente; Philip L Lorenzi; Péter Lõrincz; Marek Los; Michael T Lotze; Penny E Lovat; Binfeng Lu; Bo Lu; Jiahong Lu; Qing Lu; She-Min Lu; Shuyan Lu; Yingying Lu; Frédéric Luciano; Shirley Luckhart; John Milton Lucocq; Paula Ludovico; Aurelia Lugea; Nicholas W Lukacs; Julian J Lum; Anders H Lund; Honglin Luo; Jia Luo; Shouqing Luo; Claudio Luparello; Timothy Lyons; Jianjie Ma; Yi Ma; Yong Ma; Zhenyi Ma; Juliano Machado; Glaucia M Machado-Santelli; Fernando Macian; Gustavo C MacIntosh; Jeffrey P MacKeigan; Kay F Macleod; John D MacMicking; Lee Ann MacMillan-Crow; Frank Madeo; Muniswamy Madesh; Julio Madrigal-Matute; Akiko Maeda; Tatsuya Maeda; Gustavo Maegawa; Emilia Maellaro; Hannelore Maes; Marta Magariños; Kenneth Maiese; Tapas K Maiti; Luigi Maiuri; Maria Chiara Maiuri; Carl G Maki; Roland Malli; Walter Malorni; Alina Maloyan; Fathia Mami-Chouaib; Na Man; Joseph D Mancias; Eva-Maria Mandelkow; Michael A Mandell; Angelo A Manfredi; Serge N Manié; Claudia Manzoni; Kai Mao; Zixu Mao; Zong-Wan Mao; Philippe Marambaud; Anna Maria Marconi; Zvonimir Marelja; Gabriella Marfe; Marta Margeta; Eva Margittai; Muriel Mari; Francesca V Mariani; Concepcio Marin; Sara Marinelli; Guillermo Mariño; Ivanka Markovic; Rebecca Marquez; Alberto M Martelli; Sascha Martens; Katie R Martin; Seamus J Martin; Shaun Martin; Miguel A Martin-Acebes; Paloma Martín-Sanz; Camille Martinand-Mari; Wim Martinet; Jennifer Martinez; Nuria Martinez-Lopez; Ubaldo Martinez-Outschoorn; Moisés Martínez-Velázquez; Marta Martinez-Vicente; Waleska Kerllen Martins; Hirosato Mashima; James A Mastrianni; Giuseppe Matarese; Paola Matarrese; Roberto Mateo; Satoaki Matoba; Naomichi Matsumoto; Takehiko Matsushita; Akira Matsuura; Takeshi Matsuzawa; Mark P Mattson; Soledad Matus; Norma Maugeri; Caroline Mauvezin; Andreas Mayer; Dusica Maysinger; Guillermo D Mazzolini; Mary Kate McBrayer; Kimberly McCall; Craig McCormick; Gerald M McInerney; Skye C McIver; Sharon McKenna; John J McMahon; Iain A McNeish; Fatima Mechta-Grigoriou; Jan Paul Medema; Diego L Medina; Klara Megyeri; Maryam Mehrpour; Jawahar L Mehta; Yide Mei; Ute-Christiane Meier; Alfred J Meijer; Alicia Meléndez; Gerry Melino; Sonia Melino; Edesio Jose Tenorio de Melo; Maria A Mena; Marc D Meneghini; Javier A Menendez; Regina Menezes; Liesu Meng; Ling-Hua Meng; Songshu Meng; Rossella Menghini; A Sue Menko; Rubem Fs Menna-Barreto; Manoj B Menon; Marco A Meraz-Ríos; Giuseppe Merla; Luciano Merlini; Angelica M Merlot; Andreas Meryk; Stefania Meschini; Joel N Meyer; Man-Tian Mi; Chao-Yu Miao; Lucia Micale; Simon Michaeli; Carine Michiels; Anna Rita Migliaccio; Anastasia Susie Mihailidou; Dalibor Mijaljica; Katsuhiko Mikoshiba; Enrico Milan; Leonor Miller-Fleming; Gordon B Mills; Ian G Mills; Georgia Minakaki; Berge A Minassian; Xiu-Fen Ming; Farida Minibayeva; Elena A Minina; Justine D Mintern; Saverio Minucci; Antonio Miranda-Vizuete; Claire H Mitchell; Shigeki Miyamoto; Keisuke Miyazawa; Noboru Mizushima; Katarzyna Mnich; Baharia Mograbi; Simin Mohseni; Luis Ferreira Moita; Marco Molinari; Maurizio Molinari; Andreas Buch Møller; Bertrand Mollereau; Faustino Mollinedo; Marco Mongillo; Martha M Monick; Serena Montagnaro; Craig Montell; Darren J Moore; Michael N Moore; Rodrigo Mora-Rodriguez; Paula I Moreira; Etienne Morel; Maria Beatrice Morelli; Sandra Moreno; Michael J Morgan; Arnaud Moris; Yuji Moriyasu; Janna L Morrison; Lynda A Morrison; Eugenia Morselli; Jorge Moscat; Pope L Moseley; Serge Mostowy; Elisa Motori; Denis Mottet; Jeremy C Mottram; Charbel E-H Moussa; Vassiliki E Mpakou; Hasan Mukhtar; Jean M Mulcahy Levy; Sylviane Muller; Raquel Muñoz-Moreno; Cristina Muñoz-Pinedo; Christian Münz; Maureen E Murphy; James T Murray; Aditya Murthy; Indira U Mysorekar; Ivan R Nabi; Massimo Nabissi; Gustavo A Nader; Yukitoshi Nagahara; Yoshitaka Nagai; Kazuhiro Nagata; Anika Nagelkerke; Péter Nagy; Samisubbu R Naidu; Sreejayan Nair; Hiroyasu Nakano; Hitoshi Nakatogawa; Meera Nanjundan; Gennaro Napolitano; Naweed I Naqvi; Roberta Nardacci; Derek P Narendra; Masashi Narita; Anna Chiara Nascimbeni; Ramesh Natarajan; Luiz C Navegantes; Steffan T Nawrocki; Taras Y Nazarko; Volodymyr Y Nazarko; Thomas Neill; Luca M Neri; Mihai G Netea; Romana T Netea-Maier; Bruno M Neves; Paul A Ney; Ioannis P Nezis; Hang Tt Nguyen; Huu Phuc Nguyen; Anne-Sophie Nicot; Hilde Nilsen; Per Nilsson; Mikio Nishimura; Ichizo Nishino; Mireia Niso-Santano; Hua Niu; Ralph A Nixon; Vincent Co Njar; Takeshi Noda; Angelika A Noegel; Elsie Magdalena Nolte; Erik Norberg; Koenraad K Norga; Sakineh Kazemi Noureini; Shoji Notomi; Lucia Notterpek; Karin Nowikovsky; Nobuyuki Nukina; Thorsten Nürnberger; Valerie B O'Donnell; Tracey O'Donovan; Peter J O'Dwyer; Ina Oehme; Clara L Oeste; Michinaga Ogawa; Besim Ogretmen; Yuji Ogura; Young J Oh; Masaki Ohmuraya; Takayuki Ohshima; Rani Ojha; Koji Okamoto; Toshiro Okazaki; F Javier Oliver; Karin Ollinger; Stefan Olsson; Daniel P Orban; Paulina Ordonez; Idil Orhon; Laszlo Orosz; Eyleen J O'Rourke; Helena Orozco; Angel L Ortega; Elena Ortona; Laura D Osellame; Junko Oshima; Shigeru Oshima; Heinz D Osiewacz; Takanobu Otomo; Kinya Otsu; Jing-Hsiung James Ou; Tiago F Outeiro; Dong-Yun Ouyang; Hongjiao Ouyang; Michael Overholtzer; Michelle A Ozbun; P Hande Ozdinler; Bulent Ozpolat; Consiglia Pacelli; Paolo Paganetti; Guylène Page; Gilles Pages; Ugo Pagnini; Beata Pajak; Stephen C Pak; Karolina Pakos-Zebrucka; Nazzy Pakpour; Zdena Palková; Francesca Palladino; Kathrin Pallauf; Nicolas Pallet; Marta Palmieri; Søren R Paludan; Camilla Palumbo; Silvia Palumbo; Olatz Pampliega; Hongming Pan; Wei Pan; Theocharis Panaretakis; Aseem Pandey; Areti Pantazopoulou; Zuzana Papackova; Daniela L Papademetrio; Issidora Papassideri; Alessio Papini; Nirmala Parajuli; Julian Pardo; Vrajesh V Parekh; Giancarlo Parenti; Jong-In Park; Junsoo Park; Ohkmae K Park; Roy Parker; Rosanna Parlato; Jan B Parys; Katherine R Parzych; Jean-Max Pasquet; Benoit Pasquier; Kishore Bs Pasumarthi; Daniel Patschan; Cam Patterson; Sophie Pattingre; Scott Pattison; Arnim Pause; Hermann Pavenstädt; Flaminia Pavone; Zully Pedrozo; Fernando J Peña; Miguel A Peñalva; Mario Pende; Jianxin Peng; Fabio Penna; Josef M Penninger; Anna Pensalfini; Salvatore Pepe; Gustavo Js Pereira; Paulo C Pereira; Verónica Pérez-de la Cruz; María Esther Pérez-Pérez; Diego Pérez-Rodríguez; Dolores Pérez-Sala; Celine Perier; Andras Perl; David H Perlmutter; Ida Perrotta; Shazib Pervaiz; Maija Pesonen; Jeffrey E Pessin; Godefridus J Peters; Morten Petersen; Irina Petrache; Basil J Petrof; Goran Petrovski; James M Phang; Mauro Piacentini; Marina Pierdominici; Philippe Pierre; Valérie Pierrefite-Carle; Federico Pietrocola; Felipe X Pimentel-Muiños; Mario Pinar; Benjamin Pineda; Ronit Pinkas-Kramarski; Marcello Pinti; Paolo Pinton; Bilal Piperdi; James M Piret; Leonidas C Platanias; Harald W Platta; Edward D Plowey; Stefanie Pöggeler; Marc Poirot; Peter Polčic; Angelo Poletti; Audrey H Poon; Hana Popelka; Blagovesta Popova; Izabela Poprawa; Shibu M Poulose; Joanna Poulton; Scott K Powers; Ted Powers; Mercedes Pozuelo-Rubio; Krisna Prak; Reinhild Prange; Mark Prescott; Muriel Priault; Sharon Prince; Richard L Proia; Tassula Proikas-Cezanne; Holger Prokisch; Vasilis J Promponas; Karin Przyklenk; Rosa Puertollano; Subbiah Pugazhenthi; Luigi Puglielli; Aurora Pujol; Julien Puyal; Dohun Pyeon; Xin Qi; Wen-Bin Qian; Zheng-Hong Qin; Yu Qiu; Ziwei Qu; Joe Quadrilatero; Frederick Quinn; Nina Raben; Hannah Rabinowich; Flavia Radogna; Michael J Ragusa; Mohamed Rahmani; Komal Raina; Sasanka Ramanadham; Rajagopal Ramesh; Abdelhaq Rami; Sarron Randall-Demllo; Felix Randow; Hai Rao; V Ashutosh Rao; Blake B Rasmussen; Tobias M Rasse; Edward A Ratovitski; Pierre-Emmanuel Rautou; Swapan K Ray; Babak Razani; Bruce H Reed; Fulvio Reggiori; Markus Rehm; Andreas S Reichert; Theo Rein; David J Reiner; Eric Reits; Jun Ren; Xingcong Ren; Maurizio Renna; Jane Eb Reusch; Jose L Revuelta; Leticia Reyes; Alireza R Rezaie; Robert I Richards; Des R Richardson; Clémence Richetta; Michael A Riehle; Bertrand H Rihn; Yasuko Rikihisa; Brigit E Riley; Gerald Rimbach; Maria Rita Rippo; Konstantinos Ritis; Federica Rizzi; Elizete Rizzo; Peter J Roach; Jeffrey Robbins; Michel Roberge; Gabriela Roca; Maria Carmela Roccheri; Sonia Rocha; Cecilia Mp Rodrigues; Clara I Rodríguez; Santiago Rodriguez de Cordoba; Natalia Rodriguez-Muela; Jeroen Roelofs; Vladimir V Rogov; Troy T Rohn; Bärbel Rohrer; Davide Romanelli; Luigina Romani; Patricia Silvia Romano; M Isabel G Roncero; Jose Luis Rosa; Alicia Rosello; Kirill V Rosen; Philip Rosenstiel; Magdalena Rost-Roszkowska; Kevin A Roth; Gael Roué; Mustapha Rouis; Kasper M Rouschop; Daniel T Ruan; Diego Ruano; David C Rubinsztein; Edmund B Rucker; Assaf Rudich; Emil Rudolf; Ruediger Rudolf; Markus A Ruegg; Carmen Ruiz-Roldan; Avnika Ashok Ruparelia; Paola Rusmini; David W Russ; Gian Luigi Russo; Giuseppe Russo; Rossella Russo; Tor Erik Rusten; Victoria Ryabovol; Kevin M Ryan; Stefan W Ryter; David M Sabatini; Michael Sacher; Carsten Sachse; Michael N Sack; Junichi Sadoshima; Paul Saftig; Ronit Sagi-Eisenberg; Sumit Sahni; Pothana Saikumar; Tsunenori Saito; Tatsuya Saitoh; Koichi Sakakura; Machiko Sakoh-Nakatogawa; Yasuhito Sakuraba; María Salazar-Roa; Paolo Salomoni; Ashok K Saluja; Paul M Salvaterra; Rosa Salvioli; Afshin Samali; Anthony Mj Sanchez; José A Sánchez-Alcázar; Ricardo Sanchez-Prieto; Marco Sandri; Miguel A Sanjuan; Stefano Santaguida; Laura Santambrogio; Giorgio Santoni; Claudia Nunes Dos Santos; Shweta Saran; Marco Sardiello; Graeme Sargent; Pallabi Sarkar; Sovan Sarkar; Maria Rosa Sarrias; Minnie M Sarwal; Chihiro Sasakawa; Motoko Sasaki; Miklos Sass; Ken Sato; Miyuki Sato; Joseph Satriano; Niramol Savaraj; Svetlana Saveljeva; Liliana Schaefer; Ulrich E Schaible; Michael Scharl; Hermann M Schatzl; Randy Schekman; Wiep Scheper; Alfonso Schiavi; Hyman M Schipper; Hana Schmeisser; Jens Schmidt; Ingo Schmitz; Bianca E Schneider; E Marion Schneider; Jaime L Schneider; Eric A Schon; Miriam J Schönenberger; Axel H Schönthal; Daniel F Schorderet; Bernd Schröder; Sebastian Schuck; Ryan J Schulze; Melanie Schwarten; Thomas L Schwarz; Sebastiano Sciarretta; Kathleen Scotto; A Ivana Scovassi; Robert A Screaton; Mark Screen; Hugo Seca; Simon Sedej; Laura Segatori; Nava Segev; Per O Seglen; Jose M Seguí-Simarro; Juan Segura-Aguilar; Ekihiro Seki; Christian Sell; Iban Seiliez; Clay F Semenkovich; Gregg L Semenza; Utpal Sen; Andreas L Serra; Ana Serrano-Puebla; Hiromi Sesaki; Takao Setoguchi; Carmine Settembre; John J Shacka; Ayesha N Shajahan-Haq; Irving M Shapiro; Shweta Sharma; Hua She; C-K James Shen; Chiung-Chyi Shen; Han-Ming Shen; Sanbing Shen; Weili Shen; Rui Sheng; Xianyong Sheng; Zu-Hang Sheng; Trevor G Shepherd; Junyan Shi; Qiang Shi; Qinghua Shi; Yuguang Shi; Shusaku Shibutani; Kenichi Shibuya; Yoshihiro Shidoji; Jeng-Jer Shieh; Chwen-Ming Shih; Yohta Shimada; Shigeomi Shimizu; Dong Wook Shin; Mari L Shinohara; Michiko Shintani; Takahiro Shintani; Tetsuo Shioi; Ken Shirabe; Ronit Shiri-Sverdlov; Orian Shirihai; Gordon C Shore; Chih-Wen Shu; Deepak Shukla; Andriy A Sibirny; Valentina Sica; Christina J Sigurdson; Einar M Sigurdsson; Puran Singh Sijwali; Beata Sikorska; Wilian A Silveira; Sandrine Silvente-Poirot; Gary A Silverman; Jan Simak; Thomas Simmet; Anna Katharina Simon; Hans-Uwe Simon; Cristiano Simone; Matias Simons; Anne Simonsen; Rajat Singh; Shivendra V Singh; Shrawan K Singh; Debasish Sinha; Sangita Sinha; Frank A Sinicrope; Agnieszka Sirko; Kapil Sirohi; Balindiwe Jn Sishi; Annie Sittler; Parco M Siu; Efthimios Sivridis; Anna Skwarska; Ruth Slack; Iva Slaninová; Nikolai Slavov; Soraya S Smaili; Keiran Sm Smalley; Duncan R Smith; Stefaan J Soenen; Scott A Soleimanpour; Anita Solhaug; Kumaravel Somasundaram; Jin H Son; Avinash Sonawane; Chunjuan Song; Fuyong Song; Hyun Kyu Song; Ju-Xian Song; Wei Song; Kai Y Soo; Anil K Sood; Tuck Wah Soong; Virawudh Soontornniyomkij; Maurizio Sorice; Federica Sotgia; David R Soto-Pantoja; Areechun Sotthibundhu; Maria João Sousa; Herman P Spaink; Paul N Span; Anne Spang; Janet D Sparks; Peter G Speck; Stephen A Spector; Claudia D Spies; Wolfdieter Springer; Daret St Clair; Alessandra Stacchiotti; Bart Staels; Michael T Stang; Daniel T Starczynowski; Petro Starokadomskyy; Clemens Steegborn; John W Steele; Leonidas Stefanis; Joan Steffan; Christine M Stellrecht; Harald Stenmark; Tomasz M Stepkowski; Stęphan T Stern; Craig Stevens; Brent R Stockwell; Veronika Stoka; Zuzana Storchova; Björn Stork; Vassilis Stratoulias; Dimitrios J Stravopodis; Pavel Strnad; Anne Marie Strohecker; Anna-Lena Ström; Per Stromhaug; Jiri Stulik; Yu-Xiong Su; Zhaoliang Su; Carlos S Subauste; Srinivasa Subramaniam; Carolyn M Sue; Sang Won Suh; Xinbing Sui; Supawadee Sukseree; David Sulzer; Fang-Lin Sun; Jiaren Sun; Jun Sun; Shi-Yong Sun; Yang Sun; Yi Sun; Yingjie Sun; Vinod Sundaramoorthy; Joseph Sung; Hidekazu Suzuki; Kuninori Suzuki; Naoki Suzuki; Tadashi Suzuki; Yuichiro J Suzuki; Michele S Swanson; Charles Swanton; Karl Swärd; Ghanshyam Swarup; Sean T Sweeney; Paul W Sylvester; Zsuzsanna Szatmari; Eva Szegezdi; Peter W Szlosarek; Heinrich Taegtmeyer; Marco Tafani; Emmanuel Taillebourg; Stephen Wg Tait; Krisztina Takacs-Vellai; Yoshinori Takahashi; Szabolcs Takáts; Genzou Takemura; Nagio Takigawa; Nicholas J Talbot; Elena Tamagno; Jerome Tamburini; Cai-Ping Tan; Lan Tan; Mei Lan Tan; Ming Tan; Yee-Joo Tan; Keiji Tanaka; Masaki Tanaka; Daolin Tang; Dingzhong Tang; Guomei Tang; Isei Tanida; Kunikazu Tanji; Bakhos A Tannous; Jose A Tapia; Inmaculada Tasset-Cuevas; Marc Tatar; Iman Tavassoly; Nektarios Tavernarakis; Allen Taylor; Graham S Taylor; Gregory A Taylor; J Paul Taylor; Mark J Taylor; Elena V Tchetina; Andrew R Tee; Fatima Teixeira-Clerc; Sucheta Telang; Tewin Tencomnao; Ba-Bie Teng; Ru-Jeng Teng; Faraj Terro; Gianluca Tettamanti; Arianne L Theiss; Anne E Theron; Kelly Jean Thomas; Marcos P Thomé; Paul G Thomes; Andrew Thorburn; Jeremy Thorner; Thomas Thum; Michael Thumm; Teresa Lm Thurston; Ling Tian; Andreas Till; Jenny Pan-Yun Ting; Vladimir I Titorenko; Lilach Toker; Stefano Toldo; Sharon A Tooze; Ivan Topisirovic; Maria Lyngaas Torgersen; Liliana Torosantucci; Alicia Torriglia; Maria Rosaria Torrisi; Cathy Tournier; Roberto Towns; Vladimir Trajkovic; Leonardo H Travassos; Gemma Triola; Durga Nand Tripathi; Daniela Trisciuoglio; Rodrigo Troncoso; Ioannis P Trougakos; Anita C Truttmann; Kuen-Jer Tsai; Mario P Tschan; Yi-Hsin Tseng; Takayuki Tsukuba; Allan Tsung; Andrey S Tsvetkov; Shuiping Tu; Hsing-Yu Tuan; Marco Tucci; David A Tumbarello; Boris Turk; Vito Turk; Robin Fb Turner; Anders A Tveita; Suresh C Tyagi; Makoto Ubukata; Yasuo Uchiyama; Andrej Udelnow; Takashi Ueno; Midori Umekawa; Rika Umemiya-Shirafuji; Benjamin R Underwood; Christian Ungermann; Rodrigo P Ureshino; Ryo Ushioda; Vladimir N Uversky; Néstor L Uzcátegui; Thomas Vaccari; Maria I Vaccaro; Libuše Váchová; Helin Vakifahmetoglu-Norberg; Rut Valdor; Enza Maria Valente; Francois Vallette; Angela M Valverde; Greet Van den Berghe; Ludo Van Den Bosch; Gijs R van den Brink; F Gisou van der Goot; Ida J van der Klei; Luc Jw van der Laan; Wouter G van Doorn; Marjolein van Egmond; Kenneth L van Golen; Luc Van Kaer; Menno van Lookeren Campagne; Peter Vandenabeele; Wim Vandenberghe; Ilse Vanhorebeek; Isabel Varela-Nieto; M Helena Vasconcelos; Radovan Vasko; Demetrios G Vavvas; Ignacio Vega-Naredo; Guillermo Velasco; Athanassios D Velentzas; Panagiotis D Velentzas; Tibor Vellai; Edo Vellenga; Mikkel Holm Vendelbo; Kartik Venkatachalam; Natascia Ventura; Salvador Ventura; Patrícia St Veras; Mireille Verdier; Beata G Vertessy; Andrea Viale; Michel Vidal; Helena L A Vieira; Richard D Vierstra; Nadarajah Vigneswaran; Neeraj Vij; Miquel Vila; Margarita Villar; Victor H Villar; Joan Villarroya; Cécile Vindis; Giampietro Viola; Maria Teresa Viscomi; Giovanni Vitale; Dan T Vogl; Olga V Voitsekhovskaja; Clarissa von Haefen; Karin von Schwarzenberg; Daniel E Voth; Valérie Vouret-Craviari; Kristina Vuori; Jatin M Vyas; Christian Waeber; Cheryl Lyn Walker; Mark J Walker; Jochen Walter; Lei Wan; Xiangbo Wan; Bo Wang; Caihong Wang; Chao-Yung Wang; Chengshu Wang; Chenran Wang; Chuangui Wang; Dong Wang; Fen Wang; Fuxin Wang; Guanghui Wang; Hai-Jie Wang; Haichao Wang; Hong-Gang Wang; Hongmin Wang; Horng-Dar Wang; Jing Wang; Junjun Wang; Mei Wang; Mei-Qing Wang; Pei-Yu Wang; Peng Wang; Richard C Wang; Shuo Wang; Ting-Fang Wang; Xian Wang; Xiao-Jia Wang; Xiao-Wei Wang; Xin Wang; Xuejun Wang; Yan Wang; Yanming Wang; Ying Wang; Ying-Jan Wang; Yipeng Wang; Yu Wang; Yu Tian Wang; Yuqing Wang; Zhi-Nong Wang; Pablo Wappner; Carl Ward; Diane McVey Ward; Gary Warnes; Hirotaka Watada; Yoshihisa Watanabe; Kei Watase; Timothy E Weaver; Colin D Weekes; Jiwu Wei; Thomas Weide; Conrad C Weihl; Günther Weindl; Simone Nardin Weis; Longping Wen; Xin Wen; Yunfei Wen; Benedikt Westermann; Cornelia M Weyand; Anthony R White; Eileen White; J Lindsay Whitton; Alexander J Whitworth; Joëlle Wiels; Franziska Wild; Manon E Wildenberg; Tom Wileman; Deepti Srinivas Wilkinson; Simon Wilkinson; Dieter Willbold; Chris Williams; Katherine Williams; Peter R Williamson; Konstanze F Winklhofer; Steven S Witkin; Stephanie E Wohlgemuth; Thomas Wollert; Ernst J Wolvetang; Esther Wong; G William Wong; Richard W Wong; Vincent Kam Wai Wong; Elizabeth A Woodcock; Karen L Wright; Chunlai Wu; Defeng Wu; Gen Sheng Wu; Jian Wu; Junfang Wu; Mian Wu; Min Wu; Shengzhou Wu; William Kk Wu; Yaohua Wu; Zhenlong Wu; Cristina Pr Xavier; Ramnik J Xavier; Gui-Xian Xia; Tian Xia; Weiliang Xia; Yong Xia; Hengyi Xiao; Jian Xiao; Shi Xiao; Wuhan Xiao; Chuan-Ming Xie; Zhiping Xie; Zhonglin Xie; Maria Xilouri; Yuyan Xiong; Chuanshan Xu; Congfeng Xu; Feng Xu; Haoxing Xu; Hongwei Xu; Jian Xu; Jianzhen Xu; Jinxian Xu; Liang Xu; Xiaolei Xu; Yangqing Xu; Ye Xu; Zhi-Xiang Xu; Ziheng Xu; Yu Xue; Takahiro Yamada; Ai Yamamoto; Koji Yamanaka; Shunhei Yamashina; Shigeko Yamashiro; Bing Yan; Bo Yan; Xianghua Yan; Zhen Yan; Yasuo Yanagi; Dun-Sheng Yang; Jin-Ming Yang; Liu Yang; Minghua Yang; Pei-Ming Yang; Peixin Yang; Qian Yang; Wannian Yang; Wei Yuan Yang; Xuesong Yang; Yi Yang; Ying Yang; Zhifen Yang; Zhihong Yang; Meng-Chao Yao; Pamela J Yao; Xiaofeng Yao; Zhenyu Yao; Zhiyuan Yao; Linda S Yasui; Mingxiang Ye; Barry Yedvobnick; Behzad Yeganeh; Elizabeth S Yeh; Patricia L Yeyati; Fan Yi; Long Yi; Xiao-Ming Yin; Calvin K Yip; Yeong-Min Yoo; Young Hyun Yoo; Seung-Yong Yoon; Ken-Ichi Yoshida; Tamotsu Yoshimori; Ken H Young; Huixin Yu; Jane J Yu; Jin-Tai Yu; Jun Yu; Li Yu; W Haung Yu; Xiao-Fang Yu; Zhengping Yu; Junying Yuan; Zhi-Min Yuan; Beatrice Yjt Yue; Jianbo Yue; Zhenyu Yue; David N Zacks; Eldad Zacksenhaus; Nadia Zaffaroni; Tania Zaglia; Zahra Zakeri; Vincent Zecchini; Jinsheng Zeng; Min Zeng; Qi Zeng; Antonis S Zervos; Donna D Zhang; Fan Zhang; Guo Zhang; Guo-Chang Zhang; Hao Zhang; Hong Zhang; Hong Zhang; Hongbing Zhang; Jian Zhang; Jian Zhang; Jiangwei Zhang; Jianhua Zhang; Jing-Pu Zhang; Li Zhang; Lin Zhang; Lin Zhang; Long Zhang; Ming-Yong Zhang; Xiangnan Zhang; Xu Dong Zhang; Yan Zhang; Yang Zhang; Yanjin Zhang; Yingmei Zhang; Yunjiao Zhang; Mei Zhao; Wei-Li Zhao; Xiaonan Zhao; Yan G Zhao; Ying Zhao; Yongchao Zhao; Yu-Xia Zhao; Zhendong Zhao; Zhizhuang J Zhao; Dexian Zheng; Xi-Long Zheng; Xiaoxiang Zheng; Boris Zhivotovsky; Qing Zhong; Guang-Zhou Zhou; Guofei Zhou; Huiping Zhou; Shu-Feng Zhou; Xu-Jie Zhou; Hongxin Zhu; Hua Zhu; Wei-Guo Zhu; Wenhua Zhu; Xiao-Feng Zhu; Yuhua Zhu; Shi-Mei Zhuang; Xiaohong Zhuang; Elio Ziparo; Christos E Zois; Teresa Zoladek; Wei-Xing Zong; Antonio Zorzano; Susu M Zughaier Journal: Autophagy Date: 2016 Impact factor: 16.016
FIGURE 1
FIGURE 2
FIGURE 3
FIGURE 4
FIGURE 5